Collegium Pharmaceutical, Inc
COLLNasdaqCIK 1267565HealthcareFiscal year ends Dec 31
Reports and events: 194 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2216:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-001526 |
| 2024-02-2216:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001524 |
| 2024-01-0308:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-000579 |
| 2023-11-0908:05 ET | 8-K | 8.01 Other events | 0001104659-23-116013 |
| 2023-11-0716:04 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017983 |
| 2023-11-0716:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-017980 |
| 2023-08-2408:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-094746 |
| 2023-08-0707:40 ET | 8-K | 8.01 Other events | 0001104659-23-088079 |
| 2023-08-0316:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-013191 |
| 2023-08-0316:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-013192 |
| 2023-05-1916:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-062681 |
| 2023-05-0416:04 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-008087 |
| 2023-05-0416:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-008080 |
| 2023-04-1116:01 ET | DEF 14A | Proxy statement | 0001558370-23-005728 |
| 2023-02-2316:05 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-001900 |
| 2023-02-2316:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-001897 |
| 2023-02-1316:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-019671 |
| 2023-02-0616:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-011184 |
| 2023-01-0408:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-000644 |
| 2022-12-2208:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-129343 |
| 2022-11-0316:10 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-016241 |
| 2022-11-0316:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-016231 |
| 2022-08-0416:08 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-012184 |
| 2022-08-0416:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-012165 |
| 2022-05-2316:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-063841 |
| 2022-05-1316:01 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-22-060286 |
| 2022-05-1016:04 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-008090 |
| 2022-05-1016:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-008084 |
| 2022-04-1308:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-045273 |
| 2022-04-0616:24 ET | DEF 14A | Proxy statementPeriod 2022-05-19 | 0001558370-22-005122 |
| 2022-04-0608:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-043015 |
| 2022-04-0508:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-042561 |
| 2022-03-2307:55 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-036794 |
| 2022-02-2416:08 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-001927 |
| 2022-02-2416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-001921 |
| 2022-02-1407:42 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-021595 |
| 2021-12-2808:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-153768 |
| 2021-11-1208:00 ET | 8-K | 2.05 Exit or disposal costs | 0001104659-21-137526 |
| 2021-11-0416:03 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-014574 |
| 2021-11-0416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-014570 |
| 2021-09-3017:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-21-121292 |
| 2021-08-1608:00 ET | 8-K | 8.01 Other events | 0001104659-21-105657 |
| 2021-08-0516:18 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-010562 |
| 2021-08-0516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-010531 |
| 2021-06-0216:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-075715 |
| 2021-05-2416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-21-071141 |
| 2021-05-0616:07 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-006208 |
| 2021-05-0616:01 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-21-006197 |
| 2021-04-0716:01 ET | DEF 14A | Proxy statementPeriod 2021-05-20 | 0001558370-21-004046 |
| 2021-02-2516:09 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001558370-21-001814 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 12:06 ET. Listed shows no prices and gives no investment advice.